Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Q32 Bio Inc (QTTB)

Q32 Bio Inc (QTTB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Q32 Bio: Q2 Earnings Snapshot AP - Wed Aug 5, 6:15AM CDT

Q32 Bio: Q2 Earnings Snapshot

QTTB : 15.13 (-1.56%)
Q32 Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update PR Newswire - Wed Aug 5, 5:59AM CDT

-- Reported positive bempikibart 36-week topline results from Part B of SIGNAL-AA clinical trial; additional details from 36-week results and initial findings from 52-week results to be presented at...

QTTB : 15.13 (-1.56%)
Q32 Bio Announces Pricing of $200 Million Public Offering of Common Stock and Pre-Funded Warrants PR Newswire - Tue Jul 14, 9:58PM CDT

WALTHAM, Mass. , July 14, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB), ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata and other...

QTTB : 15.13 (-1.56%)
Q32 Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants PR Newswire - Mon Jul 13, 3:01PM CDT

WALTHAM, Mass. , July 13, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB), ("Q32 Bio") a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA")...

QTTB : 15.13 (-1.56%)
Q32 Bio Announces Positive 36-Week Topline Results from Part B of the SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata PR Newswire - Mon Jul 13, 5:59AM CDT

-- Clinically meaningful efficacy data on the primary endpoint was observed with a mean percent reduction in SALT score from baseline of 35.3% in the prespecified mITT analysis --

QTTB : 15.13 (-1.56%)
Q32 Bio to Report 36-Week Topline Results from Part B of SIGNAL-AA Clinical Trial of Bempikibart in Alopecia Areata on July 13, 2026 PR Newswire - Fri Jul 10, 3:05PM CDT

-- Conference call to be held Monday, July 13 th at 8:00 a.m. E.T. --

QTTB : 15.13 (-1.56%)
Q32 Bio Announces $55 Million Private Placement Financing PR Newswire - Wed May 27, 7:00AM CDT

WALTHAM, Mass. , May 27, 2026 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio" or "Company"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia...

QTTB : 15.13 (-1.56%)
Q32 Bio: Q1 Earnings Snapshot AP - Tue May 5, 6:05AM CDT

Q32 Bio: Q1 Earnings Snapshot

QTTB : 15.13 (-1.56%)
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update PR Newswire - Tue May 5, 5:59AM CDT

-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 --

QTTB : 15.13 (-1.56%)
Q32 Bio to Participate in the 25th Annual Needham Virtual Healthcare Conference PR Newswire - Wed Apr 8, 5:59AM CDT

WALTHAM, Mass. , April 8, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA)...

QTTB : 15.13 (-1.56%)

Barchart Exclusives

Bill Ackman Just Bought Visa Stock. What Barchart Options Data Says Could Come Next for V Investors. Barchart - 5 minutes ago
Bill Ackman reveals a fresh stake in Visa stock. Options pricing also suggests V shares will rip higher in the weeks ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.